跳至主要内容
临床试验/IRCT20200408046990N12
IRCT20200408046990N12招募中3 期

Evaluation of melatonin tablet efficacy as an adjuvant treatment for patients with mild to moderate COVID-19 in Qaem and Imam Reza Hospital, Mashhad: A triple-blind randomized placebo controlled clinical trial

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Clinical or laboratory diagnosis of mild to moderate COVID-19
  • Age between 18-85 y
  • Sign of written consent

排除标准

  • Pregnancy and lactation
  • History of allergy to melatonin
  • Immunosuppression history
  • Lactase deficiency
  • Concomitant use of alcohol and 1A2 inhibitors

研究者

相似试验